Chemed Corporation
CHE
$403.47
-$4.41-1.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.10% | 3.09% | 3.85% | 9.79% | 9.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.10% | 3.09% | 3.85% | 9.79% | 9.23% |
| Cost of Revenue | 2.04% | 8.03% | 11.38% | 11.79% | 13.26% |
| Gross Profit | -3.82% | -6.23% | -10.40% | 6.03% | 2.88% |
| SG&A Expenses | -1.39% | 3.72% | -1.89% | -4.48% | 3.80% |
| Depreciation & Amortization | 3.15% | 3.42% | 3.48% | 1.32% | 1.88% |
| Other Operating Expenses | 21.88% | -6.92% | -29.73% | -44.57% | 86.05% |
| Total Operating Expenses | 1.41% | 7.03% | 8.46% | 7.94% | 11.31% |
| Operating Income | -7.05% | -18.89% | -22.74% | 22.00% | 0.59% |
| Income Before Tax | -12.22% | -17.31% | -24.21% | 13.24% | 3.92% |
| Income Tax Expenses | -3.72% | -23.55% | -18.83% | 22.85% | 16.70% |
| Earnings from Continuing Operations | -15.02% | -15.23% | -25.95% | 10.37% | 0.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.02% | -15.23% | -25.95% | 10.37% | 0.30% |
| EBIT | -7.05% | -18.89% | -22.74% | 22.00% | 0.59% |
| EBITDA | -6.01% | -15.64% | -18.77% | 18.50% | 0.93% |
| EPS Basic | -9.81% | -11.51% | -23.38% | 14.13% | 1.96% |
| Normalized Basic EPS | -2.24% | -13.68% | -21.58% | 10.15% | 4.00% |
| EPS Diluted | -9.09% | -10.80% | -23.23% | 14.62% | 2.13% |
| Normalized Diluted EPS | -1.44% | -12.95% | -21.38% | 10.66% | 4.20% |
| Average Basic Shares Outstanding | -5.78% | -4.20% | -3.35% | -3.30% | -1.63% |
| Average Diluted Shares Outstanding | -6.55% | -5.00% | -3.59% | -3.75% | -1.82% |
| Dividend Per Share | 20.00% | 20.00% | 25.00% | 25.00% | 25.00% |
| Payout Ratio | 0.33% | 0.36% | 0.61% | 0.10% | 0.23% |